Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127149511 | 12714951 | 1 | I | 20160831 | 20160905 | 20160905 | PER | US-JNJFOC-20160901744 | JOHNSON AND JOHNSON | 70.00 | YR | E | F | Y | 78.02000 | KG | 20160905 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127149511 | 12714951 | 1 | PS | ZYRTEC | CETIRIZINE HYDROCHLORIDE | 1 | Oral | N | 19835 | TABLET | |||||||||
127149511 | 12714951 | 2 | SS | ZYRTEC | CETIRIZINE HYDROCHLORIDE | 1 | Oral | N | 19835 | 10 | MG | TABLET | |||||||
127149511 | 12714951 | 3 | C | ZYRTEC-D | CETIRIZINE HYDROCHLORIDEPSEUDOEPHEDRINE HYDROCHLORIDE | 1 | Unknown | 0 | 1 | DF | TABLET | ||||||||
127149511 | 12714951 | 4 | C | PREDNISONE. | PREDNISONE | 1 | Unknown | 0 | 2 | DF | TABLET |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
127149511 | 12714951 | 2 | Urticaria |
127149511 | 12714951 | 3 | Sinus congestion |
127149511 | 12714951 | 4 | Inflammation |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
127149511 | 12714951 | Incorrect dose administered | |
127149511 | 12714951 | Off label use | |
127149511 | 12714951 | Product use issue |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |